Abraxis is developing therapeutics for cancer and is bringing forward the first protein based nanoparticle chemotherapeutic compound, ABRAXANE.
Abraxis BioScience, Inc.
Business
Founders
Patrick Soon-Shiong
Patrick Soon-Shiong (b. 1952) is a South African-American surgeon and founder, chairman, and CEO of Abraxis BioScience, a biotechnology company developing cancer treatment.
Soon-Shiong was born in apartheid South Africa to Chinese immigrant parents, who fled from China during World War II. He...
Address
Abraxis BioScience, Inc. Headquarters
TulsaBoard members:
Ticker symbol:
| Stock exchange | Ticker symbol |
|---|---|
|
Employees and other personnel:
| Person | Title |
|---|---|
Related Topics
-
Genentech
Genentech Inc. (NYSE: DNA), a composite of Genetic Engineering Technology, Inc., is a... -
Access Pharmaceuticals Inc.
-
Merck & Co.
Merck & Co., Inc. (NYSE: MRK), also known as Merck Sharp & Dohme or MSD outside the USA and... -
Cephalon
Cephalon, Inc. (NASDAQ: CEPH) is a U.S. biopharmaceutical company co-founded in 1987 by Dr....
